Tele: 561.316.3330
Breaking Medical Device News

Monday, October 18, 2021
HomeBIOTECHNOLOGYBriotech Expands: Company Moves to a 82,000 SF Class-A Wesmar Building in...

Briotech Expands: Company Moves to a 82,000 SF Class-A Wesmar Building in Woodinville, Washington

December 23, 2020

Briotech, Inc. announced it has finalized its move into a new corporate office and manufacturing facility to support the growth in demand of Briotech’s line of Pure HOCl products.

Briotech notes that in addition to its flagship product, Briotech Topical Skin Spray, the company produces Super Oxidized Saline for oral use, and an EPA approved Multi Surface Sanitizer + Disinfectant effective against coronavirus (the novel SARS-CoV-2 pandemic virus that causes COVID-19).

Through the support of their customers, commercial and financial partners, talented staff, and our ongoing shareholder support, the company has grown so quickly this year that we have moved twice—once in February, to a functionally 2x larger space, and again this fall to this 6x larger facility where we continue to increase HOCl production and bottling capacity for our personal care, and cleaning and disinfection product lines. In addition, the BrioWHISH Network Systems that we build here in Woodinville accommodate the production of millions of gallons per day, or more, on a global basis.” said Rick Lockett, CEO of the company.

BrioHOCl is composed of salt, water, and hypochlorous acid, and unlike bleach, quaternary ammonias, alcohol, or pH neutral HOCl, BrioHOCl boasts a safety profile that makes PPE (personal protective equipment) unnecessary, presents no skin or lung irritation risks, is non-flammable, is food-contact safe, and requires no rinsing or wiping. Briotech’s BrioWHISH Systems produce the world’s first pure HOCl to be manufactured at scale with zero contaminants or buffers that reduce the competing products efficacy, safety, and stability.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Adam S. Epstein New CEO of AliMed, Inc.

In his prior role as Chief Commercial Officer, Epstein directed all customer-facing, demand generation and product development activities. Under his new leadership, AliMed will continue to build a robust portfolio of contracted positions with major, national GPO’s, IDN’s, and Distribution partners to drive sales growth.

Tony Collins Appointed CFO of Xenter

“Xenter is building a platform for medical innovations that is transformational. The only way we can achieve our objectives is if we have great leaders like Tony Collins leading our company,” stated Richard J. Linder, Founder, Chairman & CEO of Xenter, Inc. “Tony brings incredible depth and experience to his new role as Chief Financial Officer.

HistoSonics Receives FDA “Breakthrough Device Designation” for Novel Sonic Beam Therapy

Histotripsy of the liver provides clinicians the first automated external beam therapy using acoustic energy to mechanically destroy and liquefy tissue in the liver without incisions, ionizing radiation or heat.

Scott Sexton Appointed President at FIGUR8

"Scott brings to FIGUR8 30 years of workers' compensation, casualty, disability, and commercial health experience, most recently serving as a market leader for CorVel's national carrier practice sales team," said Nan-Wei Gong, CEO, and co-founder of FIGUR8.

Endolumik Inc. of Morgantown Secures $175,000 Angel Investment from Country Roads Angel Network

Endolumik, Inc. was founded in May 2020 by Mara McFadden, chief executive officer, and Dr. Nova Szoka, inventor of the surgical device.

Insulet Announces Board of Director Changes with Appointment of Luciana Borio, M.D. and Retirement of Sally W. Crawford

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced...

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

By using this website you agree to accept Medical Device News Magazine Privacy Policy